
"COVID-19 Pandemic Leads to Thousands of Missed Prostate Cancer Diagnoses"
A new study published in BJU International reveals that the COVID-19 pandemic led to a significant decrease in prostate cancer diagnoses, with a 31% drop in 2020 compared to the prior year in the U.K. This resulted in an estimated 20,000 missed prostate cancer cases in England alone. The study suggests that healthcare providers should focus on identifying the affected individuals and highlights the impact of pandemic-related disruptions on healthcare-seeking behavior and access to non-COVID-19-related healthcare services.
